ArticleSignal transduction and targeted therapy2026
Targeting GPR34 in damage-associated macrophages enhances anti-tumor immunity and the efficacy of Surufatinib in pancreatic cancer.
Xiaofan Guo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.